Getting to Know Ocular Oncologist Timothy S. Fuller, MD
May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates,
read more
Meet Our Dallas Clinical Research Coordinators
Karen Duignan, Sally Arceneaux, Ashley Hughes and Jessica Flores serve as our clinical research coordinators for Dallas. They assist patients with their enrollment and participation in our wide variety of clinical trials
read more Ocular (Uveal) Melanoma and Biopsy – the “Why” and “How” of It
By Timothy Fuller, MD, Ocular Oncologist With the diagnosis of ocular (uveal) melanoma comes the very real risk of metastatic disease, or “spread” of the cancer to other parts of the body.
read more Texas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read more
Ocular Melanoma and the Importance of Annual Dilated Eye Exams: Felicia Corbray’s Story
It was November 2017 when Felicia Corbray experienced the first fast, faint flash of light in her eye. A mother of three young children, including six-month old twins, she chalked it up
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more
Getting to Know Timothy S. Fuller, MD
Timothy S. Fuller, MD, is one of three Dr. Fullers at Texas Retina Associates. In August 2016, he joined his father Dwain Fuller, MD, and older brother Christopher Fuller, MD, at our
read more